Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Evaluating Operation Calm With Children, Parents, and Clinicians

NCT07694934 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-10-01
Last updated
2026-10-07

Condition(s) studied

Preoperative Anxiety Experienced by the Pediatric PatientDental Anxiety in ChildrenProcedural Anxiety

Investigational drug(s) / intervention(s)

Operation Calm EEMCF-VR

Operation Calm EEMCF-VR: Operation Calm is a virtual reality (VR) nature-based mindfulness intervention for children and adolescents aged 6-17 years. Children complete one brief immersive 360° nature experience paired with guided mindfulness exercises focused on paced breathing, grounding, sensory awareness, present-moment attention, and reflection on calm and safety. Each child is assigned one of five nature scenes and views the intervention using a smartphone-compatible VR headset. The intervention is designed to teach coping skills that may eventually support children facing medical or dental procedures. Parents and clinicians view the intervention through a secure online link and provide feedback. This is a single-arm feasibility study and does not include a control condition.

Study summary

Operation Calm is a single-arm, mixed-methods feasibility study evaluating a virtual reality (VR) nature-based mindfulness intervention with children and adolescents aged 6-17 years, parents, and clinicians. Children complete one guided mindfulness session combining an immersive 360° nature environment with breathing, sensory awareness, and grounding exercises. Parents and clinicians view the intervention through a secure online link. The study examines feasibility, acceptability, engagement, usability, perceived usefulness, and child tolerability. It also explores immediate changes in children's anxiety, calmness, state mindfulness, and nature connectedness. Feedback from children, parents, and clinicians will guide further refinement of Operation Calm before it is evaluated in a larger clinical study.

Eligibility

Sex
ALL
Min age
6 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria Children and Adolescents * Aged 6-17 years * Able to understand English or French * Residing in Canada * Have access to a smartphone compatible with the YouTube application and the study's smartphone-compatible VR headset * Able to view the VR intervention and complete the study questionnaires * Parent or legal guardian provides informed consent * Child provides assent, or the adolescent provides consent, as applicable based on age and ethics requirements Parents or Legal Guardians * A parent or legal guardian of a child or adolescent aged 6-17 years * Able to understand English or French * Able to view the Operation Calm intervention through a secure online link and complete the study questionnaires * Provides informed consent Clinicians * A healthcare professional with experience working with children or adolescents in medical, dental, or procedural care * Able to understand English or French * Able to view the Operation Calm intervention through a secure online link and complete the study questionnaires * Provides informed consent Exclusion Criteria Children and Adolescents * Unable to safely or comfortably use the VR headset * Unable to view the intervention or complete the questionnaires * Unable to provide assent or consent, as applicable * Parent or legal guardian does not provide informed consent * Any health, sensory, developmental, or technical limitation that, in the judgment of the research team, would prevent safe participation or completion of the study procedures Parents and Clinicians * Unable to understand English or French * Unable to view the intervention or complete the study questionnaires * Does not provide informed consent

Primary outcome measure(s)

  • Simulator sickness measured by the Pediatric Simulator Sickness Questionnaire (Peds SSQ) — Baseline and Immediately after the intervention
    Pediatric Simulator Sickness Questionnaire (Peds SSQ): A self-report questionnaire assessing simulator sickness symptoms following virtual reality exposure. Total scores range from 0 to 90, with higher scores indicating greater simulator sickness (worse tolerability).
  • Recruitment Rate — Immediately after the intervention
    Percentage of individuals who enroll in the study among all individuals approached or responding to recruitment materials. Calculated as: number enrolled ÷ number approached or responding × 100. Unit of Measure: Percentage of individuals
  • Eligibility Rate — At screening, before the intervention
    Percentage of screened individuals who meet the study eligibility criteria. Calculated as: number eligible ÷ number screened × 100.
  • Consent Rate — At enrollment, before the intervention.
    Percentage of eligible individuals who provide informed consent or parental consent and child assent, as applicable. Calculated as: number consenting ÷ number eligible × 100.
  • Intervention Completion Rate — Immediately after the intervention.
    Percentage of enrolled participants who complete the assigned Operation Calm session. Calculated as: number completing the intervention ÷ number enrolled × 100.
  • Participants Experiencing Technical Difficulties — Immediately after the intervention
    Percentage of intervention sessions during which at least one technical difficulty occurs, including difficulties involving the virtual reality headset, smartphone, video playback, audio, internet connection, or study link. Calculated as: sessions with at least one technical difficulty ÷ total sessions initiated × 100.
  • Number of Technical Difficulties — Immediately after the intervention
    Total number of technical difficulties recorded during intervention delivery. Multiple technical difficulties may be recorded during a single session.
  • Early Discontinuation Rate — Day 1, throughout the approximately 10-minute Operation Calm intervention
    Percentage of participants who begin but discontinue the Operation Calm session before completing it. Calculated as: number discontinuing early ÷ number beginning the intervention × 100.
  • Child-Rated Acceptability of Operation Calm — Immediately after completion of the intervention.
    Child-rated acceptability will be assessed using the quantitative items of the Operation Calm Child Evaluation Questionnaire. The questionnaire assesses comprehension, engagement, usability, appropriateness, perceived usefulness, and satisfaction. An overall acceptability score will be calculated as the mean of the applicable items. Higher scores indicate greater acceptability.
  • Parent-Rated Acceptability of Operation Calm — Immediately after viewing the intervention.
    Parent-rated acceptability will be assessed using the quantitative items of the Operation Calm Parent Evaluation Questionnaire. The questionnaire assesses comprehension, appropriateness, perceived usefulness, satisfaction, and perceptions of the intervention's suitability for children and adolescents. An overall acceptability score will be calculated as the mean of the applicable items. Higher scores indicate greater acceptability.
  • Clinician-Rated Acceptability of Operation Calm — Immediately after viewing the intervention.
    Clinician-rated acceptability will be assessed using the quantitative items of the Operation Calm Clinician Evaluation Questionnaire. The questionnaire assesses appropriateness, usability, perceived usefulness, satisfaction, and perceived suitability for use before medical or dental procedures. An overall acceptability score will be calculated as the mean of the applicable items. Higher scores indicate greater acceptability.

Trial sites (1)

FacilityCityRegionStatus
McGill University Montreal Canada Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07694934 on ClinicalTrials.gov ↗ ← All trials in Canada